Electrofusion of Mesenchymal Stem Cells and Islet Cells for Diabetes Therapy: A Rat Model

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Yanai, Goichi ^a   Hayashi, Takashi ^b   Zhi, Qi ^c   Yang, Kai Chiang ^d   Shirouzu, Yasumasa ^a   Shimabukuro, Takashi ^e   Hiura, Akihito ^a   Inoue, Kazutomo ^f   Sumi, Shoichiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Gakkentoshi Hospital   (Japan)

^c NANKAI UNIVERSITY   (China)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e Takeda Bio Health Research Center   (Japan)

^f Inoue Clinic Diabetes Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; CASPASE 3; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; GLUCOSE; INSULIN 1; INSULIN DERIVATIVE; KI 67 ANTIGEN; NEUROGENIN 3; OCTAMER TRANSCRIPTION FACTOR 4; STEM CELL ANTIGEN 1; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL TRANSPLANTATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROFUSION (CELL); FEASIBILITY STUDY; GENE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL RELATED GENE; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PANCREAS ISLET BETA CELL RELATED GENE; PANCREAS ISLET CELL; PANCREAS ISLET CELL FUNCTION; PROTEIN EXPRESSION; RAT; REGENERATIVE MEDICINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WEIGHT GAIN;

ANIMALS; ANTIGENS, CD; APOPTOSIS; BLOOD GLUCOSE; BODY WEIGHT; BONE MARROW CELLS; CASPASE 3; CELL FUSION; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ELECTROCHEMISTRY; FLUORESCENCE; GENE EXPRESSION REGULATION; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; NUCLEAR REPROGRAMMING; RATS; REPRODUCIBILITY OF RESULTS; STAINING AND LABELING;

RATTUS;

EID: 84878423666     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064499     Document Type: Article

References (41)

1. International Diabetes Federation (2011) The global burden. IDF diabetes atlas, fifth edition. Chapter 2, 23-44.
2. Basta G, Montanucci P, Luca G, Boselli C, Noya G, et al. (2011) Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts: four cases. Diabetes Care 34: 2406-2409.
3. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhi E, et al. (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54: 2060-2069.
4. Merani S, Shapiro AMJ, (2006) Current status of pancreatic islet transplantation. Clinical Science 110: 611-625.
5. Ryan EA, Lakey JRT, Rajotte RV, Korbutt GS, Kin T, et al. (2001) Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50: 710-719.
6. Rosenberg L, Wang R, Paraskevas S, Maysinger D, (1999) Structural and functional changes resulting from islet isolation lead to islet cell death. Surgery 126: 393-398.
7. Ilieva A, Yuan S, Wang RN, Agapitos D, Hill DJ, et al. (1999) Pancreatic islet cell survival following islet isolation: the role of cellular interactions in the pancreas. Journal of Endocrinology 161: 357-364.
8. Thomas FT, Contreras JL, Bilbao G, Ricordi C, Curiel D, et al. (1999) Anoikis, extracellular matrix, and apoptosis factors in isolated cell transplantation. Surgery 126: 299-304.
9. Berney T, Molano RD, Cattan P, Pileggi A, Vizzardelli C, et al. (2001) Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation Issue 71: 125-131.
10. Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV, (1966) Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 16: 381-390.
11. Szegezdi E, O'Reilly A, Davy Y, Vawda R, Taylor DL, et al. (2009) Stem cells are resistant to TRAIL receptor-mediated apoptosis. J Cell Mol Med 13: 4409-4414.
12. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, et al. (2001) Identification of mesenchymal stem/progenitor cells in human first-trimester fetalblood, liver, and bone marrow. Blood 98: 2396-2402.
13. Erices A, Conget P, Minguell J, (2000) Mesenchymal progenitor cells in human umbilical cord blood. British Journal of Haematology 109: 235-242.
14. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, et al. (2004) Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stemcells 22: 1338-1345.
15. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, et al. (2003) Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174: 101-109.
16. Augello A, Kurth TB, De-Bari C, (2010) Mesenchymal stem cells: A perspective from in vitro culture to in vivo migration and niches. European Cells and Materials 20: 121-133.
17. Al-Khaldi A, Eliopoulos N, Martineau D, Lejeune L, Lachapelle K, et al. (2003) Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo. Gene Ther 10: 621-629.
18. Gruber R, Kandler B, Holzmann P, Vögele-Kadletz M, Losert U, et al. (2005) Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells. Tissue Eng 11: 896-903.
19. Park KS, Kim YS, Kim JH, Choi B, Kim SH, et al. (2010) Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation. Transplantation 89: 509-517.
20. Bell GI, Broughton HC, Levac KD, Allan DA, Xenocostas A, et al. (2012) Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization. Stem Cells Dev 21: 97-109.
21. Rackham CL, Chagastelles PC, Nardi NB, Hauge-Evans AC, Jones PM, et al. (2011) Co-transplantation of mesenchymal stem cells maintains islet organisation and morphology in mice. Diabetologia 54: 1127-1135.
22. Lu Y, Jin X, Chen Y, Li S, Yuan Y, et al. (2010) Mesenchymal stem cells protect islets from hypoxia/reoxygenation-induced injury. Cell Biochem Funct 28: 637-643.
23. Berman DM, Willman MA, Han D, Kleiner G, Kenyon NM, et al. (2010) Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates. Diabetes 59: 2558-2568.
24. Chen EH, Grote E, Mohler W, Vignery A, (2007) Cell-cell fusion. FEBS Letters 581: 2181-2193.
25. Duelli D, Lazebnik Y, (2007) Cell-to-cell fusion as a link between viruses and cancer. Nature Reviews Cancer 7: 968-976.
26. Vignery A, (2008) Macrophage Fusion. Methods in Molecular Biology 475: 149-161.
27. Maltmana DJ, Hardya SA, Przyborski SA, (2011) Role of mesenchymal stem cells in neurogenesis and nervous system repair. Neurochem Int 59: 347-356.
28. Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T, (2001) Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 11: 1553-1558.
29. Qi Z, Shen Y, Yanai G, Yang K, Shirouzu Y, et al. (2010) The in vivo performance of polyvinyl alcohol macro-encapsulated islets. Biomaterials 31: 4026-4031.
30. Tanaka H, Shimizu K, Hayashi T, Shu S, (2002) Therapeutic immune response induced by electrofusion of dendritic and tumor cells. Cellular Immunology 220: 1-12.
31. Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, et al. (1990) Establishment of a pancreatic β cell line that retains glucose inducible insulin secretion: Special reference to expression of glucose transporter isoforms. Endocrinology 127: 126-132.
32. Barrera-Escorcia E, Muñóz-Torres A, Vilches-Flores A, Fregoso-Padilla M, Martínez-Aguilar J, et al. (2005) Clinical evolution of diabetic rats after transplant of electrofused pancreatic islet cells and dermic cells. Biomedicine & Pharmacotherapy 59: 275-282.
33. Okada Y, Tadokoro J, (1963) The distribution of cell fusion capacity among several cell strains or cells caused by HVJ. Exp Cell Res 32: 417-430.
34. Davidson RL, Gerald PS, (1976) Improved techniques for the induction of mammalian cell hybridization by polyethylene glycol. Somatic Cell Genet 2: 165-176.
35. Zimmermann U, (1982) Electric field-mediated fusion and related electrical phenomena. Biochim Biophys Acta 694: 227-277.
36. Soleimani M, Nadri S, (2009) A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc 4: 102-106.
37. Mortaza B, Stephen DW, Danmei L, Jane EA, Marc DG, et al. (2003) Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. PNAS 100: 5840-5845.
38. Sally AB, Elena J, (2012) Markers for Characterization of Bone Marrow Multipotential Stromal Cells. Stem Cells International 2012: 1-12.
39. Dominici M, Le BK, Mueller I, Slaper-Cortenbach I, Marini FC, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
40. Palermo A, Doyonnas R, Bhutani N, Pomerantz J, Alkan O, et al. (2009) Nuclear reprogramming in heterokaryons in rapid, extensive and bidirectional. FASEB J 23: 1431-1440.
41. Dittmar T, Seidel J, Zaenker KS, Niggemann B, (2006) Carcinogenesis driven by bone marrow-derived stem cells. Contrib Microbiol 13: 156-69.